Motor function optimization in advanced Parkinson's disease patients, combined with galantamine to prevent visual hallucinations.

Trial Profile

Motor function optimization in advanced Parkinson's disease patients, combined with galantamine to prevent visual hallucinations.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Galantamine (Primary) ; Levodopa/carbidopa
  • Indications Hallucinations; Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top